Table 4.
Variables | Univariate analyses | Multivariate analyses (enter) | Multivariate analyses (backward: LR) | ||||||
---|---|---|---|---|---|---|---|---|---|
OR | 95%CI | p-value | OR | 95%CI | p-value | OR | 95%CI | p-value | |
Initial NBS-TSH level | 1.031 | 1.020–1.043 | < 0.001 | 1.021 | 1.002–1.040 | 0.029 | 1.019 | 1.003–1.034 | 0.019 |
Initial serum TSH level | 1.009 | 1.002–1.017 | 0.017 | 0.966 | 0.984–1.009 | 0.569 | – | – | – |
LT4 dose at withdrawal | 7.243 | 3.822–13.726 | < 0.001 | 10.269 | 4.464–23.622 | < 0.001 | 6.511 | 3.16–13.41 | < 0.001 |
Enter: Nagelkerke R2: 0.476; Hosmer–Lemeshow test p value: 0.108; predicted percentage: 78.8%. Backward: LR: nagelkerke R2: 0.416; Hosmer–Lemeshow test p value: 0.316; predicted percentage: 78.8%
PCH Permanent congenital hypothyroidism, NBS Newborn screening, TSH Thyroid stimulating hormone, LT4 L-thyroxine
Initial NBS-TSH level and LT4 dose at the withdrawal were determined as predictors of PCH